Table 8. Imaging signs of pulmonary MDR-TB in children*.
Variables | HIV(−) MDR-TB (n=22) | HIV(+) MDR-TB (n=20) | ptMDR-TB (n=19) | nMDR-TB (n=26) | 0–6 years (n=18) | 6–12 years (n=27) |
---|---|---|---|---|---|---|
Cavity prevalence | 31.8% | 35% | 52.6% | 15.4% | 16.7% | 40.7% |
Pleural effusion | 13.6% | 10% | 10.5% | 10.0% | – | – |
*based on Manikkam et al. (36).